» Articles » PMID: 23414347

Structural Biology of the Proteasome

Overview
Publisher Annual Reviews
Specialty Biophysics
Date 2013 Feb 19
PMID 23414347
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

The proteasome refers to a collection of complexes centered on the 20S proteasome core particle (20S CP), a complex of 28 subunits that houses proteolytic sites in its hollow interior. Proteasomes are found in eukaryotes, archaea, and some eubacteria, and their activity is critical for many cellular pathways. Important recent advances include inhibitor binding studies and the structure of the immunoproteasome, whose specificity is altered by the incorporation of inducible catalytic subunits. The inherent repression of the 20S CP is relieved by the ATP-independent activators 11S and Blm10/PA200, whose structures reveal principles of proteasome mechanism. The structure of the ATP-dependent 19S regulatory particle, which mediates degradation of polyubiquitylated proteins, is being revealed by a combination of crystal or NMR structures of individual subunits and electron microscopy reconstruction of the intact complex. Other recent structural advances inform us about mechanisms of assembly and the role of conformational changes in the functional cycle.

Citing Articles

Molecular insights into the unique properties of the blood-circulating proteasome.

Leushkin Y, Morgenstern D, Ben-Dor S, Haffner-Krausz R, Zittlau K, Ben-Nissan G J Extracell Biol. 2025; 4(1):e70034.

PMID: 39872464 PMC: 11770374. DOI: 10.1002/jex2.70034.


Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Arseni L, Sigismondo G, Yazdanparast H, Hermansen J, Mack N, Ohl S Nat Commun. 2025; 16(1):1041.

PMID: 39863584 PMC: 11762753. DOI: 10.1038/s41467-025-56318-7.


Evaluating Antimalarial Proteasome Inhibitors for Efficacy in Blood Stage Cultures.

Robbertse L, Fajtova P, Snebergerova P, Jalovecka M, Levytska V, Barbosa da Silva E ACS Omega. 2024; 9(45):44989-44999.

PMID: 39554424 PMC: 11561622. DOI: 10.1021/acsomega.4c04564.


The Proteasome-Family-Members-Based Prognostic Model Improves the Risk Classification for Adult Acute Myeloid Leukemia.

Sheng G, Tao J, Jin P, Li Y, Jin W, Wang K Biomedicines. 2024; 12(9).

PMID: 39335660 PMC: 11429122. DOI: 10.3390/biomedicines12092147.


Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome.

Mansfield C, Quan B, Chirgwin M, Eduful B, Hughes P, Neveu G Cell Chem Biol. 2024; 31(4):729-742.e13.

PMID: 38492573 PMC: 11031320. DOI: 10.1016/j.chembiol.2024.02.008.


References
1.
Kay L . Solution NMR spectroscopy of supra-molecular systems, why bother? A methyl-TROSY view. J Magn Reson. 2011; 210(2):159-70. DOI: 10.1016/j.jmr.2011.03.008. View

2.
Tian G, Park S, Lee M, Huck B, McAllister F, Hill C . An asymmetric interface between the regulatory and core particles of the proteasome. Nat Struct Mol Biol. 2011; 18(11):1259-67. PMC: 3210322. DOI: 10.1038/nsmb.2147. View

3.
Djuranovic S, Hartmann M, Habeck M, Ursinus A, Zwickl P, Martin J . Structure and activity of the N-terminal substrate recognition domains in proteasomal ATPases. Mol Cell. 2009; 34(5):580-90. DOI: 10.1016/j.molcel.2009.04.030. View

4.
Leggett D, Hanna J, Borodovsky A, Crosas B, Schmidt M, Baker R . Multiple associated proteins regulate proteasome structure and function. Mol Cell. 2002; 10(3):495-507. DOI: 10.1016/s1097-2765(02)00638-x. View

5.
Unno M, Mizushima T, Morimoto Y, Tomisugi Y, Tanaka K, Yasuoka N . The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure. 2002; 10(5):609-18. DOI: 10.1016/s0969-2126(02)00748-7. View